U.S. Army Awards Pacific Defense Contract for CMFF Mounted Common Infrastructure
The U.S. Army has awarded Pacific Defense a multi-year contract for the Army’s C5ISR Modular Open Suite of Standards (CMOSS) Mounted Form Factor (CMFF) Mounted Common Infrastructure (MCI) —a critical step in the Army’s acceleration of networked warfighting capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251006130032/en/
Pacific Defense Multi-Domain C5ISR
Under the contract from the Program Executive Office C3N, Pacific Defense will deliver CMFF MCI systems beginning in November 2025 to support soldier experimentation, software integration, and user interface development leading to full vehicle-mounted soldier evaluations in 2026. CMFF MCI spans both ground and aviation platforms and includes plans for integration of capability including communications, command and control (C2), assured PNT (APNT), and EW/SIGINT, all integrated into one standardized a-kit vehicle envelope (SAVE) compliant chassis via plug-in-cards. As a CMFF MCI integrator, Pacific Defense will partner with the Army to accelerate mission capability insertion, drawing from a broad array of industry and government sources for critical mission hardware and software modules.
“We look forward to working with the Army to accelerate user adoption, production, and fielding of this critical, strategic technology in light of recent decisions to re-architect and rapidly re-capitalize Command and Control across echelons,” said Travis Slocumb, CEO of Pacific Defense. “Our CMFF MCI core technology enables EW/SIGINT, robust secure transport and networking, high performance tactical edge compute, APNT, and many C2 applications today with easily provisioned plug and play of cards and software into a variety of existing CMOSS chassis products.”
Pacific Defense has successfully delivered over 150 systems in use today across the U.S. and FVEY partner nations, supporting a wide spectrum of C5ISR/EW missions on ground vehicles, high altitude balloons, various airborne platforms, and fixed sites – and will soon extend into Low Earth Orbit (LEO) and Medium Earth Orbit (MEO) domains. As the pace of new emerging threats intensifies, Pacific Defense expects significant growth in deployments through 2026 and beyond.
As a leading member of the 180+ member Sensor Open Systems Approach (SOSA) Consortium, Pacific Defense has developed a robust family of SOSA/CMOSS-based mission systems. These products integrate both government and commercial hardware and software modules, enabling true multi-vendor interoperability. By leveraging SOSA/CMOSS standards, Pacific Defense ensures that its NERVE, SABER and CMFF MCI products remain adaptable, interoperable, upgradeable, and mission-ready across multiple domains, platforms, and mission sets.
Supporting Pacific Defense on the CMFF MCI effort are Thales Defense & Security Inc., BAE Systems, Palantir, MAXISIQ, Regal Technology Partners, and STC, an Arcfield company.
About Pacific Defense
Pacific Defense is purpose-built to drive the open-systems transformation required to unlock rapid innovation and the power of commercial technology. Specializing in C5ISR and Electronic Warfare (EW) solutions for mission-critical environments, Pacific Defense applies MOSA standards to deliver flexible, upgradeable technology that helps warfighters stay ahead of emerging threats. Learn more at www.pacific-defense.com and on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251006130032/en/
Contacts
Pacific Defense Media Contact
Kent Mader
marketing@pacific-defense.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release
Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
BitGo yn Sicrhau Cymeradwyaeth OCC i Drosi i Fanc Ymddiriedolaeth Genedlaethol Siartredig Ffederal13.12.2025 02:13:00 CET | Pressmeddelande
Cyhoeddodd BitGo Holdings, Inc. (“BitGo”), y cwmni seilwaith asedau digidol, heddiw fod Swyddfa Rheolwr yr Arian Cyfred (“OCC”) wedi cymeradwyo ei gais i drosi BitGo Trust Company, Inc., cwmni ymddiriedolaeth siartredig De Dakota, i fanc cenedlaethol o'r enw BitGo Bank & Trust, National Association (N.A.). Gyda chymeradwyaeth OCC heddiw o'i drosi, mae is-gwmni Cwmni Ymddiriedolaeth BitGo bellach yn gweithredu fel BitGo Bank & Trust, National Association (N.A.). Bydd BitGo Bank & Trust, N.A. yn gweithredu o dan un gyfundrefn oruchwylio ffederal unffurf, gan ei alluogi i ddarparu'r eglurder, y llywodraethiant, a'r sicrwydd rheoleiddiol y mae sefydliadau'n eu disgwyl gan ymddiriedolwr a reoleiddir yn ffederal. Mae'r gymeradwyaeth hon yn atgyfnerthu safle BitGo fel sylfaen sefydliadol ar gyfer y system ariannol fodern, gan gyfuno goruchwyliaeth ar lefel banc â'r diogelwch, y cydymffurfiaeth, a'r graddadwyedd sy'n diffinio seilwaith BitGo. O dan siarter y banc cenedlaethol, ac yn amodol ar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom